Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 1802867)

Published in World J Surg Oncol on February 07, 2007

Authors

Steve H Kim1, Kasturi Das, Shahla Noreen, Frederick Coffman, Meera Hameed

Author Affiliations

1: Department of Surgery, New Jersey Medical School/University of Medicine and Dentistry of New Jersey, Newark, NJ, USA. shkim1@geisinger.edu

Articles citing this

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene (2009) 1.97

Pathway analysis of primary central nervous system lymphoma. Blood (2008) 1.85

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol (2013) 0.99

YKL-40 tissue expression and plasma levels in patients with ovarian cancer. BMC Cancer (2009) 0.97

Insights into the biology of primary central nervous system lymphoma. Curr Oncol Rep (2009) 0.95

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer (2011) 0.93

YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas. Int J Clin Exp Pathol (2010) 0.91

High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer. PLoS One (2012) 0.84

The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma. J Cancer Res Clin Oncol (2013) 0.83

YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? Cancers (Basel) (2010) 0.83

YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment. BMC Pulm Med (2015) 0.81

Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells. PLoS One (2013) 0.78

YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling. Respir Res (2016) 0.76

Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients. Oncotarget (2016) 0.75

Articles cited by this

A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med (2001) 44.67

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med (2005) 33.60

Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med (2005) 28.25

Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull (2006) 2.69

African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer (2002) 1.94

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res (2005) 1.81

Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Cancer (2003) 1.66

A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol (1993) 1.66

Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res (1992) 1.60

Serum YKL-40 and colorectal cancer. Br J Cancer (1999) 1.57

YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun (2001) 1.46

High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res (2003) 1.42

YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res (2006) 1.39

Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer (1995) 1.31

HER2 as a prognostic and predictive marker for breast cancer. Ann Oncol (2001) 1.31

Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma. Prostate (2006) 1.24

High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat (2003) 1.21

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer (2002) 1.18

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer (2006) 1.15

High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer (2004) 1.10

Early detection and prognosis of ovarian cancer using serum YKL-40. J Clin Oncol (2004) 1.09

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol Rep (2003) 1.09

Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma. J Clin Oncol (2006) 1.04

High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia. Clin Cancer Res (2005) 1.04

The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes. J Biol Chem (2006) 1.03

Circulating YKL-40 levels during human endotoxaemia. Clin Exp Immunol (2005) 0.95

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer. Acta Obstet Gynecol Scand (2003) 0.93

HER2 status: a statistician's view. Ann Oncol (2001) 0.77

Articles by these authors

Induction of sarcomas by mutant IDH2. Genes Dev (2013) 2.02

Cytomorphologic examination of anaplastic large cell lymphoma by fine-needle aspiration cytology. Cancer (2007) 1.69

Internal validation testing for new technologies: bringing telecytopathology into the mainstream. Diagn Cytopathol (2014) 1.52

Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer (2013) 1.45

Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer (2011) 1.44

A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg (2013) 1.36

Activity of Sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res (2011) 1.31

Granular cell tumor of the extremity: magnetic resonance imaging characteristics with pathologic correlation. Skeletal Radiol (2005) 1.25

Superficial soft-tissue masses of the extremities. Radiographics (2006) 1.20

Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma. Am J Surg Pathol (2010) 1.15

Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. J Vasc Surg (2002) 1.10

Role of human HGFIN/nmb in breast cancer. Breast Cancer Res (2007) 1.06

Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J Bone Joint Surg Am (2011) 1.04

Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment. World J Surg Oncol (2008) 1.02

Family physicians expedite diagnosis of breast disease in urban minority women. J Am Board Fam Med (2007) 1.01

A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells. Arch Pathol Lab Med (2013) 1.01

Metastatic mixed acinar-neuroendocrine carcinoma of the pancreas to the liver: a cytopathology case report with review of the literature. Diagn Cytopathol (2011) 0.98

Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy. Ann Surg Oncol (2010) 0.97

Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Breast Cancer Res (2011) 0.97

Cortical chondroblastoma: report of a case and literature review of this lesion reported in unusual locations. Skeletal Radiol (2006) 0.96

Intraosseous benign notochordal cell tumor. Arch Pathol Lab Med (2010) 0.95

Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases. J Cancer Res Clin Oncol (2002) 0.95

Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. Am J Surg Pathol (2015) 0.94

Collagenous fibroma (desmoplastic fibroblastoma) with a new translocation involving 11q12: a case report. Cancer Genet Cytogenet (2009) 0.93

Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature. Diagn Pathol (2011) 0.93

Giant cell tumor of the tendon sheath mimicking a primary intramedullary metatarsal tumor. Skeletal Radiol (2012) 0.92

Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br J Haematol (2007) 0.92

Desmoplastic fibroma of the rib. Arch Pathol Lab Med (2002) 0.91

Concomitant disseminated histoplasmosis and cryptococcosis in a person with AIDS. AIDS Read (2006) 0.91

Imaging features of low-grade fibromyxoid sarcoma (Evans tumor). Skeletal Radiol (2012) 0.91

Toward better soft tissue sarcoma staging: building on american joint committee on cancer staging systems versions 6 and 7. Ann Surg Oncol (2013) 0.89

A t(12;17) in an extraorbital giant cell angiofibroma. Cancer Genet Cytogenet (2006) 0.89

Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas. Am J Clin Oncol (2002) 0.88

Cytology of metastatic appendiceal goblet cell carcinoid in pleural effusion fluid: a case report. Diagn Cytopathol (2008) 0.88

Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature. Ann Surg Oncol (2015) 0.88

Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection. J Magn Reson Imaging (2013) 0.87

A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation. J Mol Diagn (2013) 0.87

HER-2/neu and p53 in osteosarcoma: an immunohistochemical and fluorescence in situ hybridization analysis. Cancer Invest (2004) 0.86

Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. Hum Pathol (2006) 0.86

Cutaneous sarcoidosis in a woman with chronic hepatitis C and interferon therapy: a case report. Acta Cytol (2010) 0.86

Melanoma with cartilaginous differentiation originating within the mucosa of the nasal cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.86

Cystic lesions of the adrenal gland: our experience over the last 20 years. Hum Pathol (2013) 0.86

Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells. Mol Cell Biochem (2003) 0.85

Nodular fasciitis of the hand over the metacarpophalangeal joint: a case report. Eplasty (2008) 0.85

Compound clear cell sarcoma misdiagnosed as a Spitz nevus. J Cutan Pathol (2013) 0.84

Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Transplantation (2002) 0.84

Liquid-based vs. conventional smears in fine needle aspiration of bone and soft tissue tumors. Acta Cytol (2003) 0.84

Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation (2003) 0.84

A rare case of intraosseous benign notochordal cell tumor of the coccyx. Orthopedics (2009) 0.83

A translocation involving the placental growth factor gene is identified in an epithelioid hemangioendothelioma. Cancer Genet Cytogenet (2006) 0.83

Nodular pulmonary amyloidosis with an unusual protein composition diagnosed by fine-needle aspiration biopsy: a case report. Diagn Cytopathol (2009) 0.83

Periprostatic lymph node metastasis in prostate cancer and its clinical significance. Histopathology (2012) 0.83

Dedifferentiated liposarcoma of thigh with chondrosarcomatous dedifferentiated component. Am J Orthop (Belle Mead NJ) (2010) 0.83

Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center. Skeletal Radiol (2014) 0.82

Noninvasive identification of the unstable carotid plaque. Ann Vasc Surg (2006) 0.81

Simultaneous appearance of trisomy 8 and trisomy 12 in different cell populations in a patient with untreated B-cell chronic lymphocytic leukemia and myelodysplasia. Leuk Lymphoma (2004) 0.81

Non-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage. Nucleic Acids Res (2013) 0.80

Periosteal chondroma of the rib--report of a case and literature review. J Pediatr Surg (2005) 0.80

Trichoepithelioma of the vulva: report of a case and review of the literature. J Low Genit Tract Dis (2009) 0.80

The utility of 'low-grade intraepithelial lesion, cannot exclude high grade' diagnosis: a single institution's experience. Acta Cytol (2012) 0.79

p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma. Appl Immunohistochem Mol Morphol (2009) 0.79

Vulvar hidradenitis suppurativa. Immunohistochemical evaluation of apocrine and eccrine involvement. J Reprod Med (2002) 0.79

Benign notochordal cell tumors of the spine: natural history of 8 patients with histologically confirmed lesions. Neurosurgery (2013) 0.78

Percutaneous CT-guided bone biopsy: diagnosis of malignancy in lesions with initially indeterminate biopsy results and CT features associated with diagnostic or indeterminate results. AJR Am J Roentgenol (2011) 0.78

Primary alveolar soft part sarcoma of fibula demonstrating ASPL-TFE3 fusion: a case report and review of the literature. Skeletal Radiol (2008) 0.78

Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma. Pathol Res Pract (2009) 0.78

Fine-needle aspiration cytology of alveolar rhabdomyosarcoma utilizing ThinPrep liquid-based sample and cytospin preparations: a case confirmed by FKHR break apart rearrangement by FISH probe. Diagn Cytopathol (2006) 0.78

Amygdaloid kindled seizures can induce functional and pathological changes in thymus of rat: role of the sympathetic nervous system. Neurobiol Dis (2005) 0.77

Fine-needle aspiration of metastatic radiation-induced cutaneous epithelioid angiosarcoma of the breast to the liver: A diagnostic dilemma. Diagn Cytopathol (2010) 0.77

A rare case of chondromyxoid fibroma of the scapula. Am J Orthop (Belle Mead NJ) (2009) 0.77

Molecular signatures linked with aggressive behavior in basal cell carcinoma: a report of 6 cases. Am J Dermatopathol (2010) 0.77

Desmoid fibromatosis in children and adolescents: a conservative approach to management. J Pediatr Surg (2013) 0.76

Focus on technology: How important is resolution in telecytopathology? Cancer Cytopathol (2014) 0.75

Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement. J Pediatr Hematol Oncol (2016) 0.75

Detection of recurrent adenoid cystic carcinoma with PET-CT. Clin Nucl Med (2007) 0.75

Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med (2017) 0.75

Pathologic quiz case: sacral/pelvic mass with lower back pain in a 36-year-old man. Immature plasmacytoma. Arch Pathol Lab Med (2004) 0.75

Schwannoma with a reciprocal t(9;22)(q22;q13). Cancer Genet Cytogenet (2006) 0.75

Ewing sarcoma in an octogenarian: a case report. J Bone Joint Surg Am (2002) 0.75

Fine-needle aspiration cytology of mammary analog secretory carcinoma masquerading as low-grade mucoepidermoid carcinoma: case report with a review of the literature. Acta Cytol (2014) 0.75

Demonstration of her-2 protein in cervical carcinomas. J Low Genit Tract Dis (2003) 0.75

Cellular metanephric stromal tumor in a postmenopausal woman: a case report with review of the literature. Int J Surg Pathol (2012) 0.75

Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis. Int J Gynecol Pathol (2016) 0.75

A twenty-six-year-old Trinidadian woman with dizziness, nausea, and vomiting. N J Med (2005) 0.75

Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge. Diagn Cytopathol (2008) 0.75

Grading variability of urothelial carcinoma: experience from a single academic medical center. Can J Urol (2014) 0.75

Intraductal Tubulopapillary Neoplasm of the Pancreas Masquerading as Pancreatic Neuroendocrine Carcinoma: Review of the Literature with a Case Report. Acta Cytol (2016) 0.75

A 36-year-old woman with a unilateral breast mass. Necrotizing granulomatous mastitis secondary to budding yeast forms morphologically consistent with Histoplasma capsulatum. Arch Pathol Lab Med (2006) 0.75

Epithelioid sarcoma of the uterine cervix. Gynecol Oncol (2003) 0.75

Preoperative fine needle aspiration cytology diagnosis of microcystic adenoma of the pancreas: fact or fiction? A report of 2 cases. Acta Cytol (2008) 0.75

Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma. J Pediatr Hematol Oncol (2017) 0.75

GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues. Appl Immunohistochem Mol Morphol (2016) 0.75